Adlai Nortye has entered clinical collaborations with Lilly and Merck KGaA to supply cetuximab for a global Phase I trial testing AN4035, a novel pan-RAS(ON) inhibitor-based ADC, alone and with cetuximab in CEACAM5-enriched, RAS-addicted solid tumors. This trial aims to evaluate safety and preliminary efficacy, targeting cancers like colorectal and pancreatic that often have RAS mutations. The collaboration allows cetuximab supply at no cost in the US, Australia, and China, supporting a promising dual inhibition strategy for difficult-to-treat cancers. Results could expand treatment options for patients with high unmet needs.
Adlai Nortye's clinical collaboration news comes amid a health sector where 93 of 150 US stocks rose today on Pluang. For readers following health stocks, here is Pluang's market snapshot as of Oct 15, 2026 17:42 WIB: DexCom, Inc. (DXCM) gained 4.16% to USD 86.94 with 100% buy order activity, BioNano Genomics Inc (BNGO) fell 6.57% to USD 1.28 but had 100% buy orders, and AbCellera Biologics Inc (ABCL) dropped 3.72% to USD 11.91 with 98% sell orders. Typical hold times ranged from 41 to 62 days.
The Saudi Arabia Non-Invasive Prenatal Testing (NIPT) market is projected to grow from $52.5 million in 2025 to $162.16 million by 2034, at a CAGR of 13.35%. Growth is fueled by rising maternal age, advances in molecular diagnostics, and increased he...
TiDB, powered by PingCAP, announced new cloud platform capabilities to support enterprise and AI applications on a unified data foundation. Key updates include the upcoming general availability of TiDB Cloud Premium, public previews of Bring Your Own...
Alcoa will release its Q3 2026 earnings on October 15, with analysts divided on earnings per share and revenue forecasts due to factors like rising aluminum sales, inventory changes, and higher input costs. The company expects a 54.9% jump in aluminu...
Nokia has transferred 2,142,361 of its own shares to employees participating in its stock-based incentive programs, as per a board decision announced in October 2025. This transfer was made without compensation and is part of fulfilling commitments u...
Pallavi Mahajan, a senior manager at Nokia Corporation, received 35,192 shares through a share-based incentive on October 15, 2026. This transaction was reported under EU Market Abuse Regulation, reflecting Nokia's ongoing use of equity incentives to...
